Rua Bioscience Limited (NZE:RUA)

Market Cap	10.01M
Revenue (ttm)	1.83M
Net Income (ttm)	-3.46M
Shares Out	238.45M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	161,319
Average Volume	187,518
Open	0.0430
Previous Close	0.0410
Day's Range	0.0420 - 0.0430
52-Week Range	0.0230 - 0.0590
Beta	0.22
RSI	42.95
Earnings Date	Nov 26, 2025

About Rua Bioscience

Rua Bioscience Limited engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally. The company offers cannabinoid derived medicines. It is also involved in seed production and genetic discovery related activities. In addition, the company engages in plant breeding business, as well as involved in plant research activities. Rua Bioscience Limited was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. The company was founde...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: New Zealand
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: RUA

Financial Performance

In 2025, Rua Bioscience's revenue was 1.83 million, an increase of 477.39% compared to the previous year's 316,350. Losses were -3.46 million, -74.81% less than in 2024.